Katana Pharmaceuticals Competitors and Similar CompaniesClear all
Katana Pharmaceuticals's competitors and similar companies include Dermavant Sciences, Sorrento Therapeutics, ANI Pharmaceuticals and Aerie Pharmaceuticals.
 Dermavant Sciences Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology. |  Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
|  ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. |  Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. | ||
Founding Date | Founding Date N/A | Founding Date 2016 | Founding Date 2006 | Founding Date 1996 | Founding Date 2005 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Francisco, US HQ | Locations Long Beach, US HQ Basel, CH Durham, US Morrisville, US New York, US Phoenix, US | Locations San Diego, US HQ San Diego, US | Locations Baudette, US HQ Oakville, CA Baudette, US | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US |
Employees | Employees N/A | Employees 2228% decrease | Employees 31019% decrease | Employees 33813% increase | Employees 3808% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.5 m | Valuation ($) 1.2 b | Valuation ($) 722.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $62.8m (FY, 2022) | Revenue (est.) $883.4m (FY, 2025) | Revenue (est.) $194.1m (FY, 2021) |
Net income | Net income N/A | Net income ($255.3m) (FY, 2019) | Net income ($577.8m) (FY, 2022) | Net income N/A | Net income ($74.8m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 1.1m | Total funding raised $ 200m | Total funding raised $ 42.6m | Total funding raised N/A | Total funding raised $ 388.6m |
For sources of this data, please see the company profile
View Company Profiles
Dermavant Sciences
HQ
Long Beach, US
Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.
View companySorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
View companyANI Pharmaceuticals
HQ
Baudette, US
Employees
338↑ 13% increase
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
View companyAerie Pharmaceuticals
HQ
Irvine, US
Employees
380↑ 8% increase
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View company